ThomasNet Home   |   Promote Your Business
Home  |   My ThomasNet News®  |   Industry Market Trends  |   Submit Release  |   Advertise  |   About Us May 24, 2012  

Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review

Print | 
Email |  Comment   Share  

(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)

Abbott Laboratories
100 Abbott Park Rd., AP Abbott Park 5, Dept. 209
Abbott Park, IL, 60064
USA



Press release date: February 6, 2009

ABBOTT PARK, Ill., Feb. 6 -- Abbott (NYSE:ABT) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) applicable to Abbott's cash tender offer to purchase all of the outstanding shares of common stock of Advanced Medical Optics (AMO) expired last night at 11:59 p.m. Eastern time.

The expiration of the HSR waiting period satisfies one of the conditions necessary for the consummation of the tender offer. The tender offer is scheduled to expire at midnight Eastern time on Tuesday, Feb. 24, 2009, unless the tender offer is extended. Consummation of the tender offer remains subject to other customary conditions, including European Commission merger control clearance and the tender of a majority of the outstanding shares of AMO's common stock on a fully diluted basis.

As previously announced, Abbott commenced the tender offer on Jan. 27, 2009, for all of the outstanding shares of AMO common stock for $22 per share in cash. The tender offer was made pursuant to an Offer to Purchase, dated Jan. 27, 2009, and in connection with the Agreement and Plan of Merger, dated Jan. 11, 2009, entered into by and among Abbott, Rainforest Acquisition Inc., a wholly owned subsidiary of Abbott, and AMO, which Abbott and AMO announced on Jan. 12, 2009.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com/.

Source: Abbott

CONTACT: Media, Scott Stoffel +1-847-936-9502 or Financial, Tina Ventura +1-847-935-9390, both of Abbott

Web site: http://www.abbott.com/
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



Start Your Free
Subscription to
Industry Market Trends.
 More New Product News from this company:
Molecular Diagnostic System speeds identification of pathogens.
Diagnostic Instrument automates immunoassay analysis.
Immunochemistry Analyzer boosts laboratory productivity.
Catheter accesses hard-to-reach areas.
Carotid Stent treats patients at risk of stroke.
More ....
 Other News from this company:
Abbott to Present at RBC Capital Markets' Healthcare Conference
Abbott to Present at Cowen and Company Health Care Conference
Abbott to Present at Lehman Brothers Healthcare Conference
Abbott to Present at Merrill Lynch Healthcare Conference
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-Mail Story
Save Story


Home  |  My ThomasNet News®  |  Industry Market Trends  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2012 Thomas Publishing Company
Terms of Use - Privacy Policy



Error close

Please enter a valid email address